ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon Print

US and China unleash wallets in race for coronavirus vaccine

Capitals prioritize national drives over international cooperation

Countries around the world are investing big in crash programs to develop a vaccine for the coronavirus.   © Reuters

TOKYO/LONDON -- Countries around the world are shoveling huge sums at drug companies to aid development, clinical trials and mass production of COVID-19 vaccines, overshadowing coordinated global efforts.

The U.S. Biomedical Advanced Research and Development Authority has poured $1.2 billion into the hunt since early March, when the pandemic began to gain momentum in America. The office was created in 2006 under the Department of Health and Human Services to help protect the nation from bioterrorism and other threats.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more